MaxCyte, Inc.MXCTNASDAQ
Loading
R&D Expenses Over TimeStrong
Percentile Rank85
3Y CAGR+4.2%
5Y CAGR+4.5%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
+4.2%/yr
vs +14.8%/yr prior
5Y CAGR
+4.5%/yr
Consistent
Acceleration
-10.5pp
Decelerating
Percentile
P85
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
2 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$22.10M-0.6%
2024$22.23M-6.7%
2023$23.82M+22.1%
2022$19.51M+26.7%
2021$15.41M-13.1%
2020$17.73M+0.8%
2019$17.59M+56.5%
2018$11.24M-0.4%
2017$11.28M+140.3%
2016$4.70M-